CJC-1295 DAC 5mg

CJC-1295 DAC is a long-acting GHRH analogue designed to provide extended growth-hormone stimulation through its Drug Affinity Complex (DAC) attachment. This modification enhances its half-life dramatically, allowing sustained GH-release patterns in research settings. This peptide has ideal research in these categories:

1. Muscle Growth & Performance
2. Recovery & Repair
3. Longevity Support

Understanding This Peptide

The DAC variant binds to serum albumin, extending its durability within the body and allowing for prolonged GH-receptor interaction. Its long-acting nature makes it a valuable tool for examining continuous growth-hormone elevation rather than pulsatile stimulation.

Mechanism of Action

CJC-1295 DAC binds albumin via the DAC structure, ensuring slow, steady release and extended receptor activation. This creates a sustained GH increase, supporting research into long-term growth-hormone pathways, recovery, and metabolic modulation.

Scientific Interest

Researchers appreciate this peptide for its unique pharmacokinetic profile, allowing long-duration GH elevation not achievable through traditional GHRH analogues. It provides a distinct model for studying chronic GH-related effects.

Research Focus & Clinical Landscape

Active areas of investigation include:

1. long-acting GH stimulation
2. increased IGF-1 expression
3. cellular repair and recovery
4. metabolic enhancement
5. regenerative biology
6. extended hormone signaling

Its durability and binding properties continue to attract research interest worldwide.

Quality, Craftsmanship & Purity

CJC-1295 DAC is produced under strict GMP guidelines with >98% purity and third-party testing to confirm identity, potency, and consistency across batches.

Final Insight

CJC-1295 DAC provides an elegant, long-acting GH-research model, offering extended activity for studies requiring sustained hormonal signaling.